1.
Stoffers RH, Niezink AG, Chouvalova O, Ubbels JF, Woltman-van Iersel M, Hiltermann TJN, et al. Rising incidence of radiation pneumonitis after adjuvant durvalumab in NSCLC patients treated with concurrent chemoradiotherapy. AO [Internet]. 2025 Feb. 13 [cited 2025 Feb. 22];64:267-75. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/42384